Click here to subscribe to Biomedical Materials and immediately access all its archives
Click here to review the contents of the May 2006 issue of Biomedical Materials and download it online
Issue: May 2006, page: 10
Implant aids treatment of distressing condition
Following completion of the active clinical part of a Phase III study of an implant for treating central precocious puberty (CPP), or the early onset of puberty, manufacturer, Valera Pharmaceuticals Inc, plans to submit a New Drug Application (NDA) to the US Food and Drug Administration (FDA) during this second quarter of 2006.
